Terms ending in 2038
Every in-force patent on Aarhus Universitet's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,069,064 | Method and system for modelling a human heart and atria In force · High confidence | Medtrace Pharma A/S | In force | High confidence | |
| US 11,725,035 | Methods of Treating a Disorder Associated with with Insufficient Stimualtor of Interferon Genes (STING) Activity In force · High confidence | Stipe Therapeutics APS | In force | High confidence | |
| US 12,194,031 | Compounds for Use in Regulating Follicle Maturation In force · High confidence | Aarhus Universitet | In force | High confidence | |
| US 11,549,124 | NEPENTHESIN-1 Derived Resistance to Fungal Pathogens in Major Crop Plants In force · High confidence | Aarhus Universitet | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Aarhus Universitet.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.